VIYASH SCIENTIFIC LIMITED
Latest filings
- Viyash Scientific publishes notice on special window for dematerialising physical shares · Compliance
- HR leadership succession announced · Management Changes
- White Oak Capital sells 2% stake in Viyash Scientific via open market · Ownership Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹3,149 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from VIYASH SCIENTIFIC LIMITED's filed financials and exchange disclosures
What does VIYASH SCIENTIFIC LIMITED do?
VIYASH SCIENTIFIC LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol VIYASH.
Is VIYASH SCIENTIFIC LIMITED profitable?
Yes. Over the trailing twelve months VIYASH SCIENTIFIC LIMITED reported a net profit of ₹214 Cr on revenue of ₹3,149 Cr.
Does VIYASH SCIENTIFIC LIMITED pay a dividend?
Yes. The dividend yield is 0.05% at the current price. It paid out 2% of its profit as dividend in FY26.
Is VIYASH SCIENTIFIC LIMITED debt-free?
No. It reported borrowings of ₹436 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹180 Cr after cash. Debt stands at 0.14× equity. That is lower than 52% of its 166 Pharmaceuticals peers.
Is VIYASH SCIENTIFIC LIMITED expensive compared with its peers?
On trailing P/E, VIYASH SCIENTIFIC LIMITED ranks 120 of 158 in Pharmaceuticals — cheaper than 24% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the VIYASH SCIENTIFIC LIMITED share price move in a day?
On a typical session VIYASH SCIENTIFIC LIMITED moves 1.46% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track VIYASH SCIENTIFIC LIMITED's announcements?
Every NSE and BSE filing by VIYASH SCIENTIFIC LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.